Ezetimibe added to statin therapy reduces LDL-C and improves goal attainment in patients with diabetes, metabolic syndrome, or metabolic dyslipidemia

被引：0
|
作者：
McBride, P
Denke, MA
Pearson, T
Battisti, WP
Brady, WE
Palmisano, J
机构：
[1] Univ Wisconsin, Sch Med, Cardiovasc Dept, Madison, WI USA
[2] Univ Texas Hlth Sci Ctr San Antonio, Kerrville, TX USA
[3] Univ Rochester, Sch Med & Dent, Dept Community & Prevent Med, Rochester, NY USA
[4] Merck & Co Inc, Clin Dev, West Point, PA USA
来源：
DIABETOLOGIA | 2004年 / 47卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
559
引用
收藏
页码：A204 / A205
页数：2
相关论文
共 50 条
  • [1] Ezetimibe added to statin therapy reduces LDL-C and improves goal attainment in patients with diabetes and metabolic syndrome
    Denke, M
    McBride, P
    Pearson, T
    Battisti, WP
    Brady, WE
    Palmisano, J
    DIABETES, 2004, 53 : A122 - A122
  • [2] Adherence to statin therapy and LDL-C goal attainment by patients with diabetes and dyslipidemia
    Parris, ES
    Lawrence, DB
    Mohn, LA
    Long, LB
    DIABETES, 2004, 53 : A289 - A289
  • [3] Adherence to statin therapy and LDL cholesterol goal attainment by patients with diabetes and dyslipidemia
    Parris, ES
    Lawrence, DB
    Mohn, LA
    Long, LB
    DIABETES CARE, 2005, 28 (03) : 595 - 599
  • [4] Effects of ezetimibe added to on-going statin therapy on LDL-C goal attainment in high risk hypercholesterolemic patients with or without Type 2 diabetes mellitus
    Simons, L
    Masana, L
    Tonkon, M
    Shah, A
    Maccubbin, D
    Gumbiner, B
    DIABETOLOGIA, 2003, 46 : A354 - A354
  • [5] Effects of ezetimibe added to on-going statin therapy on LDL-C goal attainment in high risk hypercholesterolemic patients with or without type 2 diabetes mellitus
    Simons, L
    Tonkon, M
    Shah, A
    Maccubbin, D
    Gumbiner, B
    DIABETES, 2003, 52 : A133 - A133
  • [6] Effectiveness and safety of ezetimibe added to statin therapy in patients with primary dyslipidaemia not achieving the LDL-C treatment goal on statin monotherapy
    Gonzalez, Carlos A.
    Rubio-Guerra, Alberto F.
    Pavia, Abel
    Redding, Francisco J.
    Cervantes, Jose L.
    Zacarias, Jose L.
    Yza, Ruben
    Carranza, Jaime
    Fernandez, Pedro
    Morales, Enrique
    Robles, Francisco J.
    Leyva, Jose L.
    Rodriguez, Leticia
    CLINICAL DRUG INVESTIGATION, 2007, 27 (05) : 333 - 337
  • [7] Household income and LDL-C goal attainment in patients with diabetes and dyslipidemia in a Canadian dataset
    Farahani, Pendar
    Levine, Mitchell
    CLINICAL AND INVESTIGATIVE MEDICINE, 2014, 37 (01):
  • [8] Adherence to Statin Therapy and Attainment of LDL Cholesterol Goal Among Patients with Type 2 Diabetes and Dyslipidemia
    Alwhaibi, Monira
    Altoaimi, Maha
    AlRuthia, Yazed
    Meraya, Abdulkarim M.
    Balkhi, Bander
    Aldemerdash, Ahmed
    Alkofide, Hadeel
    Alhawassi, Tariq M.
    Alqasoumi, Abdulmajeed
    Kamal, Khalid M.
    PATIENT PREFERENCE AND ADHERENCE, 2019, 13 : 2111 - 2118
  • [9] Compliance to Statin Therapy and its Association with LDL-C Treatment Goal Attainment in China
    Li, Shenshen
    Ke, Liang
    Xie, Gaoqiang
    Zhao, Liancheng
    Zhu, Junren
    Wu, Yangfeng
    CIRCULATION, 2010, 122 (02) : E272 - E273
  • [10] Effects of ezetimibe added to statin therapy on markers of cholesterol absorption and synthesis and LDL-C lowering in hyperlipidemic patients
    Thongtang, Nuntakorn
    Lin, Jianxin
    Schaefer, Ernst J.
    Lowe, Robert S.
    Tomassini, Joanne E.
    Shah, Arvind K.
    Tershakovec, Andrew M.
    ATHEROSCLEROSIS, 2012, 225 (02) : 388 - 396
12345